Categories
Anticancer Drugs Enasidenib Oncology Pharmacology Physiotherapy

Enasidenib and Geriatric Use

In this article we will discuss Enasidenib and Geriatric Use

In this article, we will discuss Enasidenib and Geriatric Use. So, let’s get started.

Geriatric Use

No dosage adjustment is required for Enasidenib based on age. In the clinical study, 61% of 214 patients were aged 65 years or older, while 24% were older than 75 years. No overall differences in
effectiveness or safety were observed between patients aged 65 years or older and younger patients.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.